TickerFactsScreenerDevelopers

Inhibitor Therapeutics, Inc. (INTI) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$560.7K2013: -$2.00M2014: -$3.94M2015: -$3.95M2016: -$7.02M2017: -$5.12M2018: -$4.56M2019: -$2.75M2020: -$1.06M2021: -$325.4K2022: -$657.9K2023: -$3.40M2024: -$3.66M2025: -$3.43M-$3.43M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$3.43M+6.3%
2024-$3.66M-7.4%
2023-$3.40M-417.5%
2022-$657.9K-102.2%
2021-$325.4K+69.3%
2020-$1.06M+61.5%
2019-$2.75M+39.8%
2018-$4.56M+10.8%
2017-$5.12M+27.1%
2016-$7.02M-77.8%
2015-$3.95M-0.3%
2014-$3.94M-96.9%
2013-$2.00M-256.7%
2012-$560.7K—